Light Emitting Diode (LED) for the Treatment of Wrinkles
- Conditions
- Skin AgingPhotoaging of Skin
- Registration Number
- NCT00818246
- Lead Sponsor
- RoseLab Skin Optics Laboratory
- Brief Summary
The purpose of this study was to determine whether light emitting diode (LED) therapy can improve skin appearance of human subjects with aged/photoaged skin. A reduction in rhytid depth as well as in skin surface roughness and in the degree of elastosis after LED treatments was expected.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- subjects with aged/photodamaged skin
- Subjects were not allowed to participate in this study if they were taking cortisone (Prednisone), anticoagulant therapy, or any drug known to increase photosensitivity. In addition, during the 12 months preceding the study, subjects were required not to have used isotretinoin (Accutane), or applied topical steroids to the site to be treated. Moreover, previous laser or topical medication at the to-be-treated site was not permitted.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Percent Change From Baseline in Microtopographic Profilometry Ra Values (Skin Roughness). Baseline and 4 weeks Phaseshift Rapid In vivo Measurement Of Skin (PRIMOS) readings. Analysis of the data in the image is used to generate Microtopographic profilometry Ra values (skin surface roughness).
Percent Change From Baseline in Microtopographic Profilometry Rz Values (Rhytid Depth and Severity. Baseline and 4 weeks Phaseshift Rapid In vivo Measurement Of Skin (PRIMOS) readings. Analysis of the data in the image is used to generate Microtopographic profilometry Rz values (peak to valley analysis) to quantify rhytid depth and severity.
- Secondary Outcome Measures
Name Time Method Change From Baseline in Units on the Fitzpatrick Classification System (FCS) Scale for Degree of Wrinkling. Baseline and 4 weeks Clinical qualitative assessment was performed by three blinded medical observers through the evaluation of digital photographs. The photographs were analyzed for clinical improvement using the Fitzpatrick Classification System (FCS)subtype scale for degree of wrinkling (rhytids). Their assessment was rated on a five-point scale and scored as follows; 0=none; 1=mild; 2=moderate; 3=good; 4=excellent.
Number of Adverse Events. Adverse reactions were monitored throughout the study and up to 4 weeks. Signs of erythema, edema, scaling/crusting, bronzing, textural changes, hyperpigmentation, and hypopigmentation were monitored.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
RoseLab Skin Optics Laboratory
🇨🇦Montreal, Quebec, Canada
RoseLab Skin Optics Laboratory🇨🇦Montreal, Quebec, Canada
